| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |